HC Wainwright & Co. reiterated coverage on Palatin Technologies with a new price target
$PTN
Biotechnology: Pharmaceutical Preparations
Health Care
HC Wainwright & Co. reiterated coverage of Palatin Technologies with a rating of Buy and set a new price target of $5.00 from $2.00 previously